| Patents for C07K 19 - Hybrid peptides (29,428) |
|---|
| 07/12/2001 | WO2001004151A3 TUBERCULOSIS VACCINE AND DIAGNOSTICS BASED ON THE MYCOBACTERIUM TUBERCULOSIS esat-6 GENE FAMILY |
| 07/12/2001 | WO2000004041A3 Methods and molecules relating to cd39-like polypeptides |
| 07/12/2001 | US20010007755 Method for the production of conjugates and uses thereof for the prevention and treatment of allergic reactions and autoimmune diseases |
| 07/12/2001 | DE19963859A1 Bi- oder Oligomer eines Di-, Tri-, Quattro- oder Pentamers von rekombinanten Fusionsproteinen Bi- or oligomer of a di-, tri-, Quattro or pentamer of recombinant fusion proteins |
| 07/12/2001 | CA2396401A1 Novel fgf homolog zfgf12 |
| 07/12/2001 | CA2396149A1 Transduction of recombinases for inducible gene targeting |
| 07/12/2001 | CA2395945A1 Novel chimeric proteins and methods for using the same |
| 07/12/2001 | CA2395625A1 Progenitor cell preservation factors and related methods and products |
| 07/12/2001 | CA2395198A1 Pp14 fusion proteins and methods for making and using the same |
| 07/12/2001 | CA2395041A1 Stabilizing peptides, polypeptides and antibodies which include them |
| 07/12/2001 | CA2392844A1 Method for making insulin precursors and insulin precursor analogues having improved fermentation yield in yeast |
| 07/11/2001 | EP1114864A2 Mammalian cell surface antigens, related reagents |
| 07/11/2001 | EP1114152A2 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 07/11/2001 | EP1114143A1 Streptococcal c beta protein compositions |
| 07/11/2001 | EP1114062A1 MODIFIED $i(E. COLI) ENTEROTOXIN II SIGNAL PEPTIDE AND A MICROORGANISM EXPRESSING A FUSION PROTEIN OF SAID PEPTIDE AND A HETEROLOGOUS PROTEIN |
| 07/11/2001 | EP0600018B1 Hepatitis c assay utilizing recombinant antigens to c-100 region |
| 07/11/2001 | CN1303430A FAP alpha specific antibody with improved producibility |
| 07/11/2001 | CN1303394A Peptide compound for preventing and treating HIV infection and immunity diseases |
| 07/11/2001 | CN1303301A Use of anti-gp 39 antibodies for treatment and/or reversal of lupus and associated kidney disease |
| 07/11/2001 | CA2331012A1 Method for the production of conjugates and uses thereof for the prevention and treatment of allergic reactions and autoimmune diseases |
| 07/10/2001 | US6258782 Hybrid polypeptides with enhanced pharmacokinetic properties |
| 07/10/2001 | CA2060666C Antigenic epitopes present on membrane-bound but not secreted iga |
| 07/10/2001 | CA2032505C Coat transmembrane glycoprotein antigens of a hiv-2 type human retrovirus and antigens sharing immunological similarities |
| 07/05/2001 | WO2001048017A1 Intrabodies with defined framework that is stable in a reducing environment and applications thereof |
| 07/05/2001 | WO2001047953A2 Antibodies against plasma cells |
| 07/05/2001 | WO2001047950A2 Basolateral sorting signal based on scf peptide and inhibitors thereof |
| 07/05/2001 | WO2001047946A2 GFRα1-RET SPECIFIC AGONISTS AND METHODS THEREFOR |
| 07/05/2001 | WO2001047543A2 Activation and inhibition of the immune system |
| 07/05/2001 | WO2001002019A3 Control of gene expression |
| 07/05/2001 | WO2000073348A3 Methods and compositions for inhibiting neoplastic cell growth |
| 07/05/2001 | WO2000059942A3 Human obesity protein binding protrein-2 homolog and uses thereof |
| 07/05/2001 | WO2000034483A9 Compounds and methods for treatment and diagnosis of chlamydial infection |
| 07/05/2001 | WO2000023114A9 Polymer conjugates of interferon beta- 1a and their uses |
| 07/05/2001 | US20010006681 Chemokine inhibition of immunodeficiency virus |
| 07/05/2001 | CA2396039A1 Gfr.alpha.1-ret specific agonists and methods therefor |
| 07/05/2001 | CA2395236A1 Basolateral sorting signal and inhibitors thereof |
| 07/05/2001 | CA2394880A1 Activation and inhibition of the immune system |
| 07/05/2001 | CA2394295A1 Antibodies against plasma cells |
| 07/04/2001 | EP1112363A1 Metabotropic gaba receptor complex issued from the central nervous system |
| 07/04/2001 | EP1112360A1 Ecdysone receptors and methods for their use |
| 07/03/2001 | US6254870 Amino acid sequences |
| 07/03/2001 | CA2012993C Monoclonal antibodies (mabs) against tumor-associated antigens, the preparation and use thereof |
| 06/28/2001 | WO2001046357A2 Detergent compositions comprising benefit agents |
| 06/28/2001 | WO2001046231A2 Polynucleotides and polypeptides encoded thereby |
| 06/28/2001 | WO2001046228A2 Nucleic acid vaccination |
| 06/28/2001 | WO2001046224A2 Chlamydia antigens and corresponding dna fragments and uses thereof |
| 06/28/2001 | WO2001045746A2 Methods and compositions for prolonging elimination half-times of bioactive compounds |
| 06/28/2001 | WO2001045738A2 Use of heat shock proteins to enhance production of chemokines by a cell |
| 06/28/2001 | WO2001004148A3 Donor strand complemented pilin and adhesin broad-based vaccines |
| 06/28/2001 | WO2000067697A3 Nucleic acid-antibody conjugate for delivering a foreign nucleic acid in cells |
| 06/28/2001 | WO2000061753A3 Compositions and methods for the treatment and diagnosis of breast cancer |
| 06/28/2001 | WO2000055194A3 Tuberculosis antigens and methods of use therefor |
| 06/28/2001 | DE19962583A1 New antibodies specific for plasma cells, useful for treatment and diagnosis of autoimmune diseases and plasma cell tumors |
| 06/28/2001 | DE19957065A1 Screening-Verfahren für Arzneistoffe A screening method for drugs |
| 06/28/2001 | CA2395212A1 Polynucleotides and polypeptides encoded thereby |
| 06/28/2001 | CA2395208A1 Nucleic acid vaccination |
| 06/28/2001 | CA2393586A1 Use of heat shock proteins |
| 06/28/2001 | CA2390691A1 Methods and compositions for prolonging elimination half-times of bioactive compounds |
| 06/27/2001 | EP1111053A2 Peptide fragment of the respiratory syncytial virus G protein, immunogenic agent, pharmaceutical composition containing same, and preparation method |
| 06/27/2001 | EP1109921A1 Fusion receptors specific for prostate-specific membrane antigen and uses thereof |
| 06/27/2001 | EP1109920A1 Fusion proteins, dna molecules, vectors, and host cells useful for measuring protease activity |
| 06/27/2001 | EP1109918A2 Polypeptides, polynucleotides and uses thereof |
| 06/27/2001 | EP0792167B1 Monofunctional and/or polyfunctional polylysine conjugates |
| 06/27/2001 | EP0629131B1 Antigens protective against (echinococcus granulosus) infection and vaccines containing such antigens |
| 06/27/2001 | CN1301270A Protease conjugates |
| 06/27/2001 | CN1301176A Use of active P40 conjugates for nasal delivery |
| 06/26/2001 | US6252051 ErbB4 receptor-specific neuregulin related ligand antibodies and uses therefor |
| 06/26/2001 | US6252043 Fusion protein for the treatment of inflammation; for the detection and prevention of leukocyte adhesion to endothelial cells |
| 06/26/2001 | US6251867 Antiangiogenic peptides and methods for inhibiting angiogenesis |
| 06/26/2001 | US6251865 Insulin-like growth factor agonist molecules |
| 06/26/2001 | US6251628 Isolated nucleic acid molecules encoding Smad7 |
| 06/26/2001 | US6251398 Fusion proteins comprising transport proteins comprising sequences from herpesviral vp22 or fragments thereof together with an antigenic sequence greater than 12 amino acids in length |
| 06/21/2001 | WO2001044497A2 Protein kinase regulation |
| 06/21/2001 | WO2001044472A1 Tnfr/opg-like molecules and uses thereof |
| 06/21/2001 | WO2001044467A2 Method for obtaining human cdc25 phosphatases and method for identifying human cdc25 phosphatase modulators |
| 06/21/2001 | WO2001044300A2 Brain specific binding members |
| 06/21/2001 | WO2001044286A2 Five-helix protein |
| 06/21/2001 | WO2001044282A2 Bcl-g polypeptides, encoding nucleic acids and methods of use |
| 06/21/2001 | WO2001043695A2 Peptide constructs for treating autoimmune and related diseases |
| 06/21/2001 | WO2000020574A9 Fusions of scaffold proteins with random peptide libraries |
| 06/21/2001 | CA2394536A1 Tnfr/opg-like molecules and uses thereof |
| 06/21/2001 | CA2394152A1 Method for obtaining human cdc25 phosphatases and method for identifying human cdc25 phosphatase modulators |
| 06/21/2001 | CA2393292A1 Brain specific binding members |
| 06/21/2001 | CA2390662A1 Bcl-g polypeptides, encoding nucleic acids and methods of use |
| 06/20/2001 | EP1108046A1 Guanylate binding protein (gbp-1) as inhibitor of cell proliferation and molecular marker for the determination of the stage of cellular differentiation |
| 06/20/2001 | EP1108034A2 Attenuated salmonella spi2 mutants as antigen carriers |
| 06/20/2001 | EP1108015A1 Streptavidin mutants having secondary functional domains |
| 06/20/2001 | EP1107989A2 Expression and export of angiostatin and endostatin as immunofusins |
| 06/20/2001 | EP1107987A2 Novel irap-bp polypeptide and nucleic acid molecules and uses therefor |
| 06/20/2001 | EP1107979A2 Lipid matrix-assisted chemical ligation and synthesis of membrane polypeptides |
| 06/20/2001 | EP1107794A2 Recombinant botulinium toxin for the treatment of mucus hypersecretion |
| 06/20/2001 | EP1107789A1 Compositions and methods for protecting organs, tissue and cells from immune system-mediated damage |
| 06/20/2001 | CN1300295A Hybrid protein for inhibiting the deatanulation of mastocytes and the use thereof |
| 06/20/2001 | CN1299973A HCV-free-blood external preparing method |
| 06/20/2001 | CN1299870A Lycoris agglutinin protein and its code sequence |
| 06/19/2001 | US6248867 Polypeptide associated with proper eye function; for the diagnosis of vision defects |
| 06/19/2001 | US6248574 Fusion protein of polypeptide derived from gp41 or gp120 of defined amino acid sequence and a non-human immunodeficiency virus polypeptide sequence; diagnosis; immunotherapy; immunotoxins; vaccines |
| 06/19/2001 | US6248543 Detecting microbiocides in sample; mix modulator and protein in sample and detect binding of modulator and protein |
| 06/19/2001 | US6248532 Detecting modulators of regulatory element; incubate nucleotide sequences with modulators, monitor binding to nucleotide sequences, comparing binding in the presence and absence modulators |
| 06/19/2001 | US6248516 Library for expression of immunoglobulin heavy chain variable domains |